MCR RAS Lab @ UoM
LightNews LightNews
banner
mcrraslab.bsky.social
MCR RAS Lab @ UoM
@mcrraslab.bsky.social
78 followers 44 following 4 posts
RAS Research Lab at University of Manchester, led by Dr.Colin Lindsay. Unravelling RAS mutations in cancer. Research driven by patients. #RASResearch #KRAS #LungCancer
Posts Replies Media Videos
Reposted by MCR RAS Lab @ UoM
drcolinlindsay.bsky.social
Here is the wonderful Dr Ana Parreira presenting her poster on KRASm radiotherapy outcomes at #BTOG2025

Ana is a Portuguese medical oncologist bridging the clin med oncology divide with unrelenting diplomacy and discipline!

@mcrcnews.bsky.social
March 4, 2025 at 11:44 AM
Reposted by MCR RAS Lab @ UoM
drcolinlindsay.bsky.social
Our excellent LCNEC project manager, Karen Shackcloth, presenting her poster yesterday at #BTOG2025

Her dedication to this role has been critical for our SIG efforts towards moving towards standardised diagnostic and management LCNEC pathways
March 4, 2025 at 4:33 PM
mcrraslab.bsky.social
📢Shaping the Future of Cancer Research
🗓️Thur 13 March, 11am–12pm
📍Zoom

Join Dr Colin Lindsay, Clinical Senior Lecturer in Medical Oncology @UoM, to learn about the latest advances in lung cancer research.

🔗Register: zoom.us/webinar/regi...

@drcolinlindsay.bsky.social

#lungcancer #medicaloncology
Welcome! You are invited to join a webinar: Shaping the future of cancer research. After registering, you will receive a confirmation email about joining the webinar.
The University of Manchester is a world-leader in cancer research. Join Dr Colin Lindsay as he shares the realities of cancer research, and the strides he has made in combatting lung cancer. Legacy ...
zoom.us
March 11, 2025 at 12:49 PM
mcrraslab.bsky.social
Productive RAS team lab meeting this morning, discussing the challenges of targeting KRAS G13D. A tough mutation to tackle, but some interesting discussions on potential strategies. Onward with the work! #CancerResearch #KRAS #RAS #G13D #Manchester #TheChristie #UoM
March 6, 2025 at 1:08 PM
Reposted by MCR RAS Lab @ UoM
drcolinlindsay.bsky.social
Other thing at the end of 2024 - I caught up with my friend and tireless advocate for KRAS research, Terri Conneran of KRAS Kickers, for a webinar on RAS translation.
www.youtube.com/channel/UCUI...

@official-uom.bsky.social @cancerresearchuk.org @cruk-mi.bsky.social @kraskickers.bsky.social
KRAS Kickers
Lung, pancreatic and colon cancers are the 3 deadliest cancers. KRAS is the cancer biomarker driving most of those cancers. KRAS Kickers is a non profit group for patients, that want to kick cancer'...
www.youtube.com
January 15, 2025 at 4:50 PM
Reposted by MCR RAS Lab @ UoM
drcolinlindsay.bsky.social
We had a fantastic end to 2024 in the Manchester RAS lab www.mcrc.manchester.ac.uk/research/dis...

Our 1st PhD student passed his viva...George Morrissey is now beginning med onc training and is destined for great things.
@official-uom.bsky.social @cruk-mi.bsky.social
January 15, 2025 at 4:44 PM
mcrraslab.bsky.social
We attended the 2nd Annual CGI-Clinics Meeting in Barcelona, where partners shared key updates on the CGI tool, patient engagement, & AI-driven diagnostics. A fantastic opportunity to reflect on progress and shape the next steps for precision oncology! #CGIClinics #CancerResearch #PrecisionOncology
Second Annual Meeting 2025 of the CGI-Clinics Project - cgiclinics.eu
We met in Barcelona, Spain on 23 - 24 January 2025 for the second Annual Meeting of the CGI-Clinics project, which has just entered its third year. The consortium came together to share updates and ac...
www.cgiclinics.eu
February 6, 2025 at 11:02 AM
Reposted by MCR RAS Lab @ UoM
uom-dcs.bsky.social
Today is #WorldCancerDay!

👋 We are officially here on Bluesky 🦋. We are the Division of Cancer Sciences, within @official-uom.bsky.social – representing clinicians, scientists, technicians and students; all working together to demystify cancer.

🔔 Follow us to hear news and updates.
#TeamManchester
February 4, 2025 at 7:21 AM
mcrraslab.bsky.social
🚨Exciting! The Malliri & Lindsay team’s 1st KRAS paper is out in Molecular Cancer!

KRASG12D drives NSCLC more potently than KRASG12C, linked to PI3K-AKT-mTOR. Co-targeting KRASG12D & AKT shows synergy in vitro & in vivo.

📰Read: rdcu.be/dZZqo

#CancerResearch #KRAS
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer
rdcu.be
December 5, 2024 at 12:06 PM